MoonLake Immunotherapeutics - Class A (MLTX) Company Profile & Statistics

MoonLake Immunotherapeutics - Class A
MLTX
(Nasdaq - US)
N/A
40.10
-0.59 (-1.45%)
in:usd•As of: May 16, 2024 12:58 UTC -4
Open
40.46
High
40.56
Low
39.41

About MoonLake Immunotherapeutics - Class A

CEO

Jorge Santos da Silva

Headquarters

dorfstrasse 29

zug, v8 6300, switzerland

Auditor

Baker Tilly US, LLP

Employees

Share Holders

Website

www.moonlaketx.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

MoonLake Immunotherapeutics AG is a clinical-stage biotechnology company. It focused on creating next-level therapies for inflammatory skin and joint diseases. MoonLake Immunotherapeutics AG, formerly known as Helix Acquisition Corp., is based in BOSTON.

MoonLake Immunotherapeutics - Class A Statistics

Valuation Measures

Market Capitalization ²	2.60B
Enterprise Value	2.15B
Enterprise Value/EBITDA (ttm)	-39.80
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	4.72
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-7.92%
Return on Invested Capital (ttm)	-27.05%
Return on Assets (ttm)	-7.76%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-54.11M
Net Income Avi to Common (ttm)	-36.01M
Diluted EPS (ttm)	-0.75

Share Statistics

Beta (5Y Monthly)	1.29
52-Week Change	48.74%
S&P500 52-Week Change	29.34%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	63.89M
Dividend Yield	0.00%
Float ⁴	56.21M
% Held by Insiders	12.02%
% Held by Institutions	93.85%

Balance Sheet

Total Cash (mrq)	511.01M
Total Cash Per Share (mrq)	8.00
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	51.59%
Quick Ratio (mrq)	62.12%
Book Value Per Share (mrq)	8.15

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.87
Free Cash Flow (ytd)	-43.06M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

MoonLake Immunotherapeutics - Class A

Trade With A Regulated Broker